Akili, Inc. (AKLI)
Jul 2, 2024 - AKLI was delisted (reason: acquired by Virtual Therapeutics)
0.433
+0.001 (0.25%)
Inactive · Last trade price on Jul 1, 2024

Akili Revenue

Akili had revenue of $383.00K in the quarter ending March 31, 2024, with 238.94% growth. This brings the company's revenue in the last twelve months to $1.95M, up 426.49% year-over-year. In the year 2023, Akili had annual revenue of $1.68M with 419.50% growth.

Revenue (ttm)
$1.95M
Revenue Growth
+426.49%
P/S Ratio
17.50
Revenue / Employee
$28,647
Employees
68
Market Cap
34.10M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.68M1.36M419.50%
Dec 31, 2022323.00K-215.00K-39.96%
Dec 31, 2021538.00K-3.40M-86.34%
Dec 31, 20203.94M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.